Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1650406

	registered interest
	date	05/07/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Heart Diseases: Waiting Lists
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce waiting times for heart procedures.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	192615
	answer	answer is ministerial correction date of answer 11/07/2023 answer text <p>The ‘Delivery Plan for Tackling the COVID-19 Backlog of Elective Care’ outlines how the National Health Service will bring down waiting times across all elective services. The plan does not detail approaches for each specialty but commits to eradicate all waits of longer than a year for elective care by March 2025, except for in the case of patient choice.</p><p /><p>To support this plan and tackle waiting lists, including those for heart procedures, the Government has committed more than £8 billion from 2022/23 to 2024/25 to drive up and protect elective activity.</p><p> </p><p>The Department has also been supporting local areas to recover delivery of the NHS Health Check, which aims to prevent heart attacks and strokes, and detect disease earlier. It assesses the top risk factors for cardiovascular diseases and helps people to reduce their risk by supporting them to make healthier choices and access clinical care. The latest data shows that by April 2023 delivery activity had returned to pre-pandemic levels. The Department is also taking forward a programme of work to increase access to the programme, investing nearly £17 million in the development of an innovative digital NHS Health Check.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 192616 question first answered 11/07/2023 09:14:09 answering member 4423 label Biography information for Will Quince
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1650407

	registered interest
	date	05/07/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cardiovascular Diseases: Waiting Lists
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce waitlists for NHS cardiovascular care services.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	192616
	answer	answer is ministerial correction date of answer 11/07/2023 answer text <p>The ‘Delivery Plan for Tackling the COVID-19 Backlog of Elective Care’ outlines how the National Health Service will bring down waiting times across all elective services. The plan does not detail approaches for each specialty but commits to eradicate all waits of longer than a year for elective care by March 2025, except for in the case of patient choice.</p><p /><p>To support this plan and tackle waiting lists, including those for heart procedures, the Government has committed more than £8 billion from 2022/23 to 2024/25 to drive up and protect elective activity.</p><p> </p><p>The Department has also been supporting local areas to recover delivery of the NHS Health Check, which aims to prevent heart attacks and strokes, and detect disease earlier. It assesses the top risk factors for cardiovascular diseases and helps people to reduce their risk by supporting them to make healthier choices and access clinical care. The latest data shows that by April 2023 delivery activity had returned to pre-pandemic levels. The Department is also taking forward a programme of work to increase access to the programme, investing nearly £17 million in the development of an innovative digital NHS Health Check.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 192615 question first answered 11/07/2023 09:14:09 answering member 4423 label Biography information for Will Quince
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1669928

	registered interest
	date	14/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lead: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she made of the impact of lead pollution on (a) children's and (b) other people's health.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	1940
	answer	answer is ministerial correction date of answer 21/11/2023 answer text <p>Exposure to lead can result in a range of adverse health effects, including effects on the cardiovascular, immune, reproductive and neurological systems. Unborn and young children are particularly at risk as lead exposure can adversely affect development of the nervous system.</p><p>Several measures have been implemented in the United Kingdom to reduce exposure to lead, including the phasing out of lead in paint, petrol, food cans and water pipes. The UK Health Security Agency (UKHSA) runs the Lead Exposure in Children Surveillance System (LEICSS), for reporting cases of elevated lead exposure in England. The aim of LEICSS is to facilitate public health action in individual cases, to reduce the effects of lead exposure.</p><p>Information on the health effects of lead is available at the following link: <br> <a href="https://www.gov.uk/government/publications/lead-properties-incident-management-and-toxicology" target="_blank">https://www.gov.uk/government/publications/lead-properties-incident-management-and-toxicology</a>.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 21/11/2023 11:22:04 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1695837

	registered interest
	date	13/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Consent to Medical Treatment: Pupils
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the use of Gillick competence for vaccinations in schools.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	18534
	answer	answer is ministerial correction date of answer 18/03/2024 answer text <p>The Gillick competence is a guideline used to determine whether children can provide informed consent based on their level of intelligence, knowledge, and competence. In schools, where requests for parental consent haven’t been responded to, vaccinators may ask for the child’s parents’ contact details to seek oral consent over the phone. For young people, and children in secondary school settings who may be offered the measles, mumps and rubella vaccine alongside other school aged vaccinations, after every attempt to gain parental consent has been exhausted, the School Aged Immunisation Service team may make a clinical decision to give the vaccination using the Gillick competence framework. This allows a child to consent to their own treatment where appropriate, and when they are competent to do so.</p><p>The Green Book Chapter two, Information for public health professionals on immunisation, provides guidance on seeking consent for vaccination, including the use of the Gillick competence. Obtaining consent to treatment and assessing the adequacy of the use of the Gillick competence in schools is the responsibility of each service provider.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/03/2024 17:43:06 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1695838

	registered interest
	date	13/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the adequacy of levels of parental (a) choice and (b) responsibility to decide the medical care their child receives.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	18535
	answer	answer is ministerial correction date of answer 18/03/2024 answer text <p>No assessment has been made of the adequacy of levels of parental choice and responsibility to decide the medical care their child receives. Those with parental responsibilities are entitled to give consent for medical treatment on behalf of their children. However, they are not entitled to inappropriate treatment for their children, or to refuse treatment which is in the child’s best interests.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/03/2024 17:52:24 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1665741

	registered interest
	date	18/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he plans to take to allocate remaining funding from the People at the Heart of Care funding for adult social care reform.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	203360
	answer	answer is ministerial correction date of answer 26/10/2023 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 26/10/2023 10:42:04 answering member 4527 label Biography information for Helen Whately
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1669738

	registered interest
	date	13/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Reform
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she plans to take to allocate remaining funding from the People at the Heart of Care funding for adult social care reform.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	1653
	answer	answer is ministerial correction date of answer 17/11/2023 answer text <p>In July 2023, the Department allocated this remaining funding to the Market Sustainability Improvement Fund, with £570 million allocated over the next two years. This fund is designed to maximise the impact of our system reform by further improving workforce recruitment and retention.</p><p>All other reform funding has been allocated.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 17/11/2023 15:09:56 answering member 4527 label Biography information for Helen Whately
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1670385

	registered interest
	date	15/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tumours: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NICE assessments of rare tumour type treatments consider both the failure rate of radiotherapy and the success rate of new treatments.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	2190
	answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>In its evaluations of new health technologies, including for rare diseases, the National Institute for Health and Care Excellence (NICE) takes into account all health-related costs and benefits, including evidence of comparative outcomes against existing treatment options such as radiotherapy. Full details of the process and methods used by NICE in undertaking evaluations are set out in NICE health technology evaluations: the manual, published on the NICE website and available at the following link:</p><p><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nice.org.uk%2Fprocess%2Fpmg36%2Fchapter%2Fintroduction-to-health-technology-evaluation&amp;data=05%7C01%7CMD.Support%40dhsc.gov.uk%7C333109cf26904e79aba608dbe7825f03%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C638358319347196670%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=hNltwwubSKJyLzQAyiKcpnHhf45seq1SehLv59TkbCo%3D&amp;reserved=0" target="_blank">https://www.nice.org.uk/process/pmg36/chapter/introduction-to-health-technology-evaluation</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/11/2023 16:42:51 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1670388

	registered interest
	date	15/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure non-stageable cancers are included in the NHS early diagnosis target.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	2191
	answer	answer is ministerial correction date of answer 22/11/2023 answer text <p>The NHS Long Term Plan set an ambition that, by 2028, the proportion of cancers diagnosed at stages 1 and 2 will rise from around half now to three-quarters of cancer patients. Achieving this will mean that, from 2028, 55,000 more people each year will survive their cancer for at least five years after diagnosis. Due to the nature of the ambition, this only includes stageable cancers.</p><p>To find and diagnosed all cancers earlier, NHS England is streamlining cancer pathways to support diagnosis within 28 days by implementing non-symptom specific (NSS) pathways for patients who present with non-specific symptoms that can indicate several cancers, as well as implementing timed cancer pathways.</p><p>Since 2019, cancer alliances have been developing new dedicated urgent diagnostic pathways for these patients so that every cancer patient with concerning, but non-specific symptoms, gets the right tests at the right time in as few visits as possible. By March 2024, the NSS programme will achieve full population coverage across England for non-specific symptom pathways as set out in the 2023/24 NHS Planning Guidance.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/11/2023 11:10:53 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1670389

	registered interest
	date	15/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Commercial Clinical Trials in the UK Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department has taken to implement the (a) significant actions under problem statement 6 and (b) other recommendations of the Lord O'Shaughnessy review of commercial clinical trials.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	2192
	answer	answer is ministerial correction date of answer 21/11/2023 answer text <p>The Government will soon publish a full response to the Lord O’Shaughnessy independent review into commercial clinical trials.</p><p>The response will include an update on progress and implementation of the initial five headline commitments and foundational actions that the Government made in May 2023 as well as all other recommendations in the review.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/11/2023 16:03:12 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4498 label Biography information for Mr Ranil Jayawardena